Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes

PURPOSE: The clinical relevancy of the 7-subtype classification of triple-negative breast cancer (TNBC) reported by Lehmann and Bauer et al is unknown. We investigated the clinical relevancy of TNBC heterogeneity by determining pathological complete response (pCR) rates after neoadjuvant chemotherap...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Masuda, Hiroko, Baggerly, Keith A., Wang, Ying, Zhang, Ya, Gonzalez-Angulo, Ana Maria, Meric-Bernstam, Funda, Valero, Vicente, Lehmann, Brian D., Pietenpol, Jennifer A., Hortobagyi, Gabriel N., Symmans, W. Fraser, Ueno, Naoto T.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3813597/
https://ncbi.nlm.nih.gov/pubmed/23948975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0799
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki